Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crosslink Capital is an early-stage venture capital firm investing in disruptive technology companies across enterprise and consumer sectors. It has backed over 400 companies with more than $4.6 billion under management and has supported 17 IPOs and over 50 exits. The firm's Alpha Network provides portfolio support through connections with over 2,000 industry leaders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crosslink Capital.